Skip to main content
. 2021 Mar 5;70(6):1404–1413. doi: 10.2337/db20-1167

Table 1.

Characteristics of study participants at Y15 by BMI status at Y15

Normal weight at Y15 (BMI <25 kg/m2, N = 345) Overweight at Y15 (BMI 25–30 kg/m2, N = 394) With obesity at Y15 (BMI ≥30 kg/m2, N = 318) P
Age, mean (SD) 40.2 (3.4) 40.6 (3.4) 40.2 (3.6) 0.307
Sex, n (%)
 Male 141 (40.9) 243 (61.7) 150 (47.2) <0.001
 Female 204 (59.1) 151 (38.3) 168 (52.8)
Race, %
 Black 98 (28.4) 150 (38.1) 175 (55.0) <0.001
 White 247 (71.6) 244 (61.9) 143 (45.0)
Years of education, mean (SD) 15.5 (2.8)a 15.2 (2.3)b 14.5 (2.4)a,b <0.001
Smoking status, n (%)
 Never 210 (61.2) 249 (63.4) 200 (63.1) 0.906
 Former 62 (18.1) 72 (18.3) 53 (16.7)
 Current 71 (20.7) 72 (18.3) 64 (20.2)
Heavy alcohol drinking, n (%) 33 (9.6) 48 (12.2) 19 (6.0) 0.019
Physical activity score, mean (SD) 397.2 (286.5)a 382.3 (288.6)b 291.2 (240.5)a,b <0.001
EDII score at Y25, mean (SD) 0.35 (0.89)a 0.56 (0.76)b 0.69 (0.74)a,b <0.001
Study center, n (%)
 Birmingham, AL 70 (20.3) 94 (23.9) 84 (26.4) 0.420
 Chicago, IL 81 (23.5) 79 (20.1) 69 (21.7)
 MN 89 (25.8) 115 (29.2) 81 (25.5)
 Oakland, CA 105 (30.4) 106 (26.9) 84 (26.4)
Family history of T2D, n (%) 66 (19.1) 66 (16.8) 89 (28.0) <0.001
Fasting glucose at Y15 (mg/dL), mean (SD) 90.5 (8.9)a,c 94.9 (11.0)a,b 99.8 (16.9)b,c <0.001
Fasting insulin at Y15 (μU/mL), mean (SD) 6.9 (4.5)a,c 8.6 (5.5)a,b 13.8 (8.1)b,c <0.001
Positive GrimAA at Y15, n (%) 101 (29.3) 134 (34.0) 145 (45.6) <0.001
Positive GrimAA at Y20, n (%) 104 (30.1) 129 (32.7) 136 (42.8) 0.001
Positive 5yr GrimAA, n (%) 123 (35.7) 150 (38.1) 117 (36.8) 0.750

Global P values were obtained from Student t tests for continuous variables and χ2 tests for categorical variables.

Empirical dietary inflammatory index. Values with same superscript are significantly different.